Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population

Objective To examine the prevalence of lower urinary tract symptoms (LUTS) in males of the general population. Materials and Methods In our analysis, we included 8627 men, 48-79 years of age, who participated in the fourth follow-up (FUP) of EPIC-Heidelberg (2007-2009) and replied to questions on LU...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 2016-09, Vol.95, p.158-163
Hauptverfasser: Rohrmann, Sabine, Katzke, Verena, Kaaks, Rudolf
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 163
container_issue
container_start_page 158
container_title Urology (Ridgewood, N.J.)
container_volume 95
creator Rohrmann, Sabine
Katzke, Verena
Kaaks, Rudolf
description Objective To examine the prevalence of lower urinary tract symptoms (LUTS) in males of the general population. Materials and Methods In our analysis, we included 8627 men, 48-79 years of age, who participated in the fourth follow-up (FUP) of EPIC-Heidelberg (2007-2009) and replied to questions on LUTS. According to the International Prostate Symptom Score questionnaire, men were categorized as having mild (0-7 points), moderate (8-19 points), or severe LUTS (20-35 points). In addition, we examined progression of LUTS among 7821 men, who also participated in FUP 5 (2010-2012). Results There were 75.3% of men who reported mild, 22.0% who reported moderate, and 2.7% who reported severe LUTS. The prevalence increased with age. At FUP 4, 5.8% (mild symptoms) to 39.7% (severe LUTS) of participants reported use of any type of benign prostatic hyperplasia or LUTS medication. Nocturia, that is, getting up at night at least twice, was the most common symptom, followed by incomplete emptying of the bladder and urgency. There were 54.8% of men who reported worse LUTS in FUP 5, but 27.1% reported an improvement in symptoms. Conclusion About a quarter of middle-aged and elderly men reported clinically relevant LUTS. Whereas symptoms in some men actually improve, more than half of men experience worsening of symptoms over a 3-year period in time.
doi_str_mv 10.1016/j.urology.2016.06.021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1814657417</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090429516303120</els_id><sourcerecordid>1814657417</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-5acba9b199201290977555c71a65885f553de2de8e089fea01827d797022f56f3</originalsourceid><addsrcrecordid>eNqFkU2P0zAQhi0EYsvCTwD5yCVl7MR2fAGtVnxJlSja3bPlOpPKJbGLnSzqv8dRCwcuSCPNWHrfGc8zhLxmsGbA5LvDek5xiPvTmpfnGkpw9oSsmOCq0lqLp2QFoKFquBZX5EXOBwCQUqrn5IqruikVW5Hv24SPdsDgkNrQ0W2K-4Q5-xho7Okm_sJEH5IPNp3ofbJuonen8TjFMVMfioXe7H3Y0208zoOdiu0ledbbIeOrS74mD58-3t9-qTbfPn-9vdlUrmnlVAnrdlbvmNbl_1yDVkoI4RSzUrSt6IWoO-Qdtgit7tECa7nqlFbAeS9kX1-Tt-e-xxR_zpgnM_rscBhswDhnw1rWSKEapopUnKUuxZwT9uaY_Fg2MgzMQtMczIWmWWgaKMFZ8b25jJh3I3Z_XX_wFcGHswDLoo8ek8nOLyw7n9BNpov-vyPe_9PBDT54Z4cfeMJ8iHMKhaJhJnMD5m456XJRJmuoGYf6N6DKnPg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1814657417</pqid></control><display><type>article</type><title>Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Rohrmann, Sabine ; Katzke, Verena ; Kaaks, Rudolf</creator><creatorcontrib>Rohrmann, Sabine ; Katzke, Verena ; Kaaks, Rudolf</creatorcontrib><description>Objective To examine the prevalence of lower urinary tract symptoms (LUTS) in males of the general population. Materials and Methods In our analysis, we included 8627 men, 48-79 years of age, who participated in the fourth follow-up (FUP) of EPIC-Heidelberg (2007-2009) and replied to questions on LUTS. According to the International Prostate Symptom Score questionnaire, men were categorized as having mild (0-7 points), moderate (8-19 points), or severe LUTS (20-35 points). In addition, we examined progression of LUTS among 7821 men, who also participated in FUP 5 (2010-2012). Results There were 75.3% of men who reported mild, 22.0% who reported moderate, and 2.7% who reported severe LUTS. The prevalence increased with age. At FUP 4, 5.8% (mild symptoms) to 39.7% (severe LUTS) of participants reported use of any type of benign prostatic hyperplasia or LUTS medication. Nocturia, that is, getting up at night at least twice, was the most common symptom, followed by incomplete emptying of the bladder and urgency. There were 54.8% of men who reported worse LUTS in FUP 5, but 27.1% reported an improvement in symptoms. Conclusion About a quarter of middle-aged and elderly men reported clinically relevant LUTS. Whereas symptoms in some men actually improve, more than half of men experience worsening of symptoms over a 3-year period in time.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2016.06.021</identifier><identifier>PMID: 27346671</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Age Factors ; Aged ; Disease Progression ; Humans ; Lower Urinary Tract Symptoms - diagnosis ; Lower Urinary Tract Symptoms - epidemiology ; Male ; Middle Aged ; Prevalence ; Prospective Studies ; Time Factors ; Urology</subject><ispartof>Urology (Ridgewood, N.J.), 2016-09, Vol.95, p.158-163</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-5acba9b199201290977555c71a65885f553de2de8e089fea01827d797022f56f3</citedby><cites>FETCH-LOGICAL-c486t-5acba9b199201290977555c71a65885f553de2de8e089fea01827d797022f56f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.urology.2016.06.021$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27346671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rohrmann, Sabine</creatorcontrib><creatorcontrib>Katzke, Verena</creatorcontrib><creatorcontrib>Kaaks, Rudolf</creatorcontrib><title>Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>Objective To examine the prevalence of lower urinary tract symptoms (LUTS) in males of the general population. Materials and Methods In our analysis, we included 8627 men, 48-79 years of age, who participated in the fourth follow-up (FUP) of EPIC-Heidelberg (2007-2009) and replied to questions on LUTS. According to the International Prostate Symptom Score questionnaire, men were categorized as having mild (0-7 points), moderate (8-19 points), or severe LUTS (20-35 points). In addition, we examined progression of LUTS among 7821 men, who also participated in FUP 5 (2010-2012). Results There were 75.3% of men who reported mild, 22.0% who reported moderate, and 2.7% who reported severe LUTS. The prevalence increased with age. At FUP 4, 5.8% (mild symptoms) to 39.7% (severe LUTS) of participants reported use of any type of benign prostatic hyperplasia or LUTS medication. Nocturia, that is, getting up at night at least twice, was the most common symptom, followed by incomplete emptying of the bladder and urgency. There were 54.8% of men who reported worse LUTS in FUP 5, but 27.1% reported an improvement in symptoms. Conclusion About a quarter of middle-aged and elderly men reported clinically relevant LUTS. Whereas symptoms in some men actually improve, more than half of men experience worsening of symptoms over a 3-year period in time.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Disease Progression</subject><subject>Humans</subject><subject>Lower Urinary Tract Symptoms - diagnosis</subject><subject>Lower Urinary Tract Symptoms - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>Prospective Studies</subject><subject>Time Factors</subject><subject>Urology</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2P0zAQhi0EYsvCTwD5yCVl7MR2fAGtVnxJlSja3bPlOpPKJbGLnSzqv8dRCwcuSCPNWHrfGc8zhLxmsGbA5LvDek5xiPvTmpfnGkpw9oSsmOCq0lqLp2QFoKFquBZX5EXOBwCQUqrn5IqruikVW5Hv24SPdsDgkNrQ0W2K-4Q5-xho7Okm_sJEH5IPNp3ofbJuonen8TjFMVMfioXe7H3Y0208zoOdiu0ledbbIeOrS74mD58-3t9-qTbfPn-9vdlUrmnlVAnrdlbvmNbl_1yDVkoI4RSzUrSt6IWoO-Qdtgit7tECa7nqlFbAeS9kX1-Tt-e-xxR_zpgnM_rscBhswDhnw1rWSKEapopUnKUuxZwT9uaY_Fg2MgzMQtMczIWmWWgaKMFZ8b25jJh3I3Z_XX_wFcGHswDLoo8ek8nOLyw7n9BNpov-vyPe_9PBDT54Z4cfeMJ8iHMKhaJhJnMD5m456XJRJmuoGYf6N6DKnPg</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Rohrmann, Sabine</creator><creator>Katzke, Verena</creator><creator>Kaaks, Rudolf</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160901</creationdate><title>Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population</title><author>Rohrmann, Sabine ; Katzke, Verena ; Kaaks, Rudolf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-5acba9b199201290977555c71a65885f553de2de8e089fea01827d797022f56f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Disease Progression</topic><topic>Humans</topic><topic>Lower Urinary Tract Symptoms - diagnosis</topic><topic>Lower Urinary Tract Symptoms - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>Prospective Studies</topic><topic>Time Factors</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rohrmann, Sabine</creatorcontrib><creatorcontrib>Katzke, Verena</creatorcontrib><creatorcontrib>Kaaks, Rudolf</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rohrmann, Sabine</au><au>Katzke, Verena</au><au>Kaaks, Rudolf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>95</volume><spage>158</spage><epage>163</epage><pages>158-163</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><abstract>Objective To examine the prevalence of lower urinary tract symptoms (LUTS) in males of the general population. Materials and Methods In our analysis, we included 8627 men, 48-79 years of age, who participated in the fourth follow-up (FUP) of EPIC-Heidelberg (2007-2009) and replied to questions on LUTS. According to the International Prostate Symptom Score questionnaire, men were categorized as having mild (0-7 points), moderate (8-19 points), or severe LUTS (20-35 points). In addition, we examined progression of LUTS among 7821 men, who also participated in FUP 5 (2010-2012). Results There were 75.3% of men who reported mild, 22.0% who reported moderate, and 2.7% who reported severe LUTS. The prevalence increased with age. At FUP 4, 5.8% (mild symptoms) to 39.7% (severe LUTS) of participants reported use of any type of benign prostatic hyperplasia or LUTS medication. Nocturia, that is, getting up at night at least twice, was the most common symptom, followed by incomplete emptying of the bladder and urgency. There were 54.8% of men who reported worse LUTS in FUP 5, but 27.1% reported an improvement in symptoms. Conclusion About a quarter of middle-aged and elderly men reported clinically relevant LUTS. Whereas symptoms in some men actually improve, more than half of men experience worsening of symptoms over a 3-year period in time.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27346671</pmid><doi>10.1016/j.urology.2016.06.021</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-4295
ispartof Urology (Ridgewood, N.J.), 2016-09, Vol.95, p.158-163
issn 0090-4295
1527-9995
language eng
recordid cdi_proquest_miscellaneous_1814657417
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Age Factors
Aged
Disease Progression
Humans
Lower Urinary Tract Symptoms - diagnosis
Lower Urinary Tract Symptoms - epidemiology
Male
Middle Aged
Prevalence
Prospective Studies
Time Factors
Urology
title Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T15%3A26%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20Progression%20of%20Lower%20Urinary%20Tract%20Symptoms%20in%20an%20Aging%20Population&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Rohrmann,%20Sabine&rft.date=2016-09-01&rft.volume=95&rft.spage=158&rft.epage=163&rft.pages=158-163&rft.issn=0090-4295&rft.eissn=1527-9995&rft_id=info:doi/10.1016/j.urology.2016.06.021&rft_dat=%3Cproquest_cross%3E1814657417%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1814657417&rft_id=info:pmid/27346671&rft_els_id=S0090429516303120&rfr_iscdi=true